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Abstract
Background: Successful HIV testing, care and treatment policy implementation is essential for realising the reductions
in morbidity and mortality those policies are designed to target. While adoption of new HIV policies is rapid, less is
known about the facility-level implementation of new policies and the factors influencing this.
Methods: We assessed implementation of national policies about HIV testing, treatment and retention at health facilities
serving two health and demographic surveillance sites (HDSS) (10 in Kyamulibwa, 14 in Rakai). Ugandan Ministry of Health
HIV policy documents were reviewed in 2013, and pre-determined indicators were extracted relating to the content and
nature of guidance on HIV service provision. Facility-level policy implementation was assessed via a structured
questionnaire administered to in-charge staff from each health facility. Implementation of policies was classified as wide
(≥75% facilities), partial (26–74% facilities) or minimal (≤25% facilities). Semi-structured interviews were conducted with key
informants (policy-makers, implementers, researchers) to identify factors influencing implementation; data were analysed
using the Framework Method of thematic analysis.
Results: Most policies were widely implemented in both HDSS (free testing, free antiretroviral treatment (ART), WHO
first-line regimen as standard, Option B+). Both had notable implementation gaps for policies relating to retention on
treatment (availability of nutritional supplements, support groups or isoniazid preventive therapy). Rakai implemented
more policies relating to provision of antiretroviral treatment than Kyamulibwa and performed better on quality of care
indicators, such as frequency of stock-outs. Factors facilitating implementation were donor investment and support,
strong scientific evidence, low policy complexity, phased implementation and effective planning. Limited human
resources, infrastructure and health management information systems were perceived as major barriers to effective
implementation.
Conclusions: Most HIV policies were widely implemented in the two settings; however, gaps in implementation
coverage prevail and the value of ensuring complete coverage of existing policies should be considered against the
adoption of new policies in regard to resource needs and health benefits.
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Background
The response to the HIV/AIDS epidemic has been un-
precedented in its accumulation and application of re-
search knowledge for policy and practice development
[1]. Significant progress has been made, as marked by
the achievement of Millennium Development Goal 6,
with an estimated 30 million new HIV infections averted
and 7.8 million AIDS-related deaths prevented since
2000 [2]. The effectiveness of treatment programmes in
reducing HIV-related mortality, however, is predicated
on effective implementation of policies around HIV test-
ing, care and treatment to ensure timely treatment initi-
ation and retention [3]. Recent systematic reviews
suggest heavy attrition of people living with HIV
(PLHIV) at all stages of the care continuum, resulting in
persistently higher mortality in the HIV-positive popula-
tion compared to those who are HIV negative [4]. This
raises the question about the extent to which appropri-
ate policies exist, the extent to which they are imple-
mented and factors that facilitate or disable policy
implementation.
Uganda has a large and growing population of PLHIV
(currently estimated 1.6 million) [5]. Data from two
health and demographic surveillance sites (HDSS) in
rural Uganda indicate that while mortality had substan-
tially declined since the introduction of anti-retroviral
treatment (ART) in 2004 (from 90 deaths per 1000 per-
son years in Kyamulibwa and 96.2 deaths per 1000 per-
son years in Rakai to 22.7 deaths and 22.5 deaths per
1000 person years, respectively), there continues to be
substantially higher mortality in the HIV-positive popu-
lation compared to the HIV-negative population (HIV-
negative mortality rates were 8.6 deaths and 3.4 deaths
per 1000 person years for Kyamulibwa and Rakai,
respectively) (Table 1) [6]. Reviewing current policy in
relation to its implementation in health facilities to iden-
tify gaps in service provision in these two settings may
provide insight into the factors contributing to the
higher mortality rates observed in PLHIV.
A study by Church et al. on behalf of the network for
Analysing Longitudinal Population-based HIV data in
Africa (ALPHA) reviewed the content of policies relating
to HIV testing, treatment and retention in six sub-
Saharan African countries (Kenya, Malawi, South Africa,
Tanzania, Uganda, Zimbabwe) and found substantial
variability in national policy adoption and the extent to
which policies adhere to WHO guidelines [7]. While
policy reviews are valuable in terms of understanding
national-level policy formulation, their translation into
practice can often occur incompletely or with unex-
pected outcomes, and these resulting gaps in care
provision may be hypothesised to explain observed
health outcomes. The extent to which policies are imple-
mented in different settings is unknown, and there may
be variation by facility level or at specific stages on the
continuum of HIV care. Political, social or structural fac-
tors are likely to play a role in differences between coun-
tries about how policy is put into practice [8, 9].
Figure 1 presents a framework of factors that are consid-
ered to be important in the health policy implementa-
tion process. The framework combines theoretical
insights from Walt and Gilson’s health policy triangle
(actors, content, context, process), as well as Damschroder’s
Consolidated Framework on Implementation Research
(CFIR) [10, 11]. This latter framework incorporates five do-
mains (characteristics of the intervention, characteristics of
individuals, process, inner and outer setting) and 12 con-
structs within those domains. The adapted framework is
used here to understand political, social and structural pro-
cesses influencing HIV policy implementation.
Reviewing policy implementation status, and assessing
the influences that contribute, is critical for ensuring a
more effective policy cycle, from formulation through to
delivery, and back into re-formulation. This study aims
to compare the status of implementation of policies pro-
moting access to HIV testing, treatment and retention
on treatment for facilities serving the population of two
health and demographic surveillance sites (HDSS) in
southern Uganda: Kyamulibwa and Rakai.
Methods
Study setting
This analysis forms part of a larger study by ALPHA on
HIV-related mortality; thus, the two Ugandan HDSS
sites that contribute data to the ALPHA Network are
Table 1 Background characteristics of the study sites
Kyamulibwa Rakai
Site history
Start of demographic data collection and
serosurveys
Nov-89 Apr-99
Number of clinics (surveyed/total in HDSS) 10/3a 14/17
Size (km2) 28 320
Adults (15+ years) under surveillance, 2013 9697 20,055
ART indicators
Introduction of ART Jan-04 Jun-04
Full ART implementation Jan-05 Jun-06
HIV indicators
HIV prevalence (2013) (%) 9.4 12.5
HIV−ve mortality rate, 2009–2011 (per 1000) 8.6 3.4
Pre-ART HIV+ve mortality rate (2000–2003)
(per 1000)
90 96.2
Post-ART HIV+ve mortality rate (2009–2011)
(per 1000)
22.7 22.5
Source: [6, 22]
aSix facilities outside of the HDSS that also serve the population of Kyamulibwa
were also included in the analysis
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investigated. Both HDSS are located in pre-dominantly
rural Ugandan regions. Kyamulibwa, run by the UK
Medical Research Council/Uganda Virus Research
Institute, is located within Kalungu District and began
collecting demographic and health data on the popula-
tion in 1989 [12]. Rakai, run by the Rakai Health
Sciences Program, is located within Rakai District and
began its open-community cohort for 15–49 year olds in
1994 [12]. Background characteristics of the two sites
are displayed in Table 1.
Policy review and document analysis
A review of Ugandan HIV policy documents was con-
ducted in the study by Church et al. [5]. This involved
an online and library search for any relevant ministerial
or national guideline documents on HIV counselling and
testing (HCT), prevention of mother to child transmis-
sion (PMTCT) and HIV care and treatment published
between 2003 and 2013. Staff from the Ministry of
Health were also contacted in person in order to access all
iterations of guidelines. The review captured detailed pol-
icy information (including year of formulation and any
subsequent changes) for 54 indicators influencing access
to HCT, access to care and treatment and retention in
care. The content was reviewed and compared against
successive iterations of WHO guidelines.
Health facility survey data and analysis
A health facility survey was subsequently carried out in
2013 by the ALPHA network to investigate reported
practice in areas considered to influence access to HIV
care services [13]. Detailed methods are described else-
where [13]. In total, 24 facilities were surveyed. In
Kyamulibwa, this included the three facilities located
within the HDSS and a further six on the edge of or just
outside the HDSS used by residents (n = 10). In Rakai,
all facilities were surveyed except three very small clinics
(n = 14). A structured questionnaire was administered to
in-charge staff within three types of service units of par-
ticipating facilities: HCT, PMTCT and ART services (the
latter two where operational). Descriptive statistics were
produced using STATA 13.0, including cross-tabulations
of key indicators by site and by size of facility. Statis-
tical tests were not conducted, as these were non-
random samples, and not necessarily representative of
a wider population of health facilities. Where data
were missing, the denominator reflects the proportion
of responses only, highlighted in the table.
Analysis to assess facility-level policy implementation
The policy review classified policies as explicit or not ex-
plicit (absent, vague or imprecise). Implementation of
each policy was assessed using data from the health
facility survey. Policies were defined as widely imple-
mented if equal to or more than 75% facilities enacted
the policy, partially implemented if implementation
occurred in 26–74% of facilities and minimally imple-
mented if 25% or fewer facilities reported implementa-
tion. Results were colour-coded green-orange-red to
represent the degree of implementation, and dark or
light shading was used to illustrate if policy was explicit
or not explicit. Results were grouped into different pol-
icy domains, derived from the conceptual framework de-
veloped by Church et al.: service access and coverage,
coordination of patient care and tracking, support to
PLHIV, medical management and quality of care [7].
Findings for quality of care are presented separately.
Key informant interviews
Seven semi-structured interviews were conducted with
key informants who were purposively sampled based on
their knowledge of the Ugandan HIV policy and practice
context, including individuals with experience of policy-
making (Ministry of Health, Uganda AIDS Commission),
programme implementation (a donor partner relevant to
the HDSS, a district health officer for a HDSS region
and senior management from each HDSS) or HIV policy
research in Uganda. Respondents were invited to partici-
pate by email, and informed consent was obtained. Inter-
views were conducted after the policy and practice
comparisons had been undertaken to enable discussion
of site-specific implementation gaps and to explore differ-
ences between sites. Interviews were conducted in-person
or by telephone, recorded and transcribed. Follow-up
Fig. 1 Theoretical framework to guide the analysis of factors influencing the translation of policy to practice
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interviews were conducted with respondents most familiar
with programme implementation in the HDSS to investi-
gate site-specific differences. Names and titles were re-
moved to protect anonymity. Data were managed in
Nvivo10. A deductive coding approach was used based on
a priori knowledge of implementation theories, frameworks
and models. The framework approach was used for ana-
lysis: data from each node (code) were extracted and en-
tered into a matrix and memos were elaborated in order to
reflect on the data and consider possible interpretations.
Results
An overview of the facilities surveyed is presented in
Table 2. Facilities were large health centres (serving a
population of approx. 20,000 with both out- and in- pa-
tient services) or smaller out-patient-only clinics (60% in
Kyamulibwa, 85.7% in Rakai). More facilities were
government-run in Rakai (85.7%) than those in Kyamu-
libwa (40%). All facilities provided HCT and HIV care and
treatment; in Kyamulibwa, only 80% had an ANC clinic
with each of these providing PMTCT. Human resources
were similar across both sites in regard to median num-
bers of clinicians, nurses/midwives and counsellors in
facilities; however, there were stark disparities in the staff
to client ratios: Rakai had much higher numbers of pa-
tients per staff member per week for HCT (58 clients per
week, compared to 19 per week in Kyamulibwa) and ART
(49 per week, compared to 3 per week in Kyamulibwa).
Staff turnover was broadly similar, but with a larger range
in Kyamulibwa.
Findings of reported practice compared to policy
Across both sites, the majority of policies relating to
HIV testing, treatment and retention in care were widely
implemented; however, there was some variability be-
tween sites. The year of national policy adoption does
not appear to influence implementation.
Implementation of policies promoting access to HIV
testing
Table 3 summarises policy implementation for HCT ser-
vices. Of 12 explicit policies reviewed, eight were widely
implemented in both Kyamulibwa and Rakai (six were the
same policies). Implementation gaps differed between
sites: fewer facilities in Kyamulibwa implemented policies
relating to service coverage and access, and facilities in
Table 2 Overview of Kyamulibwa and Rakai HDSS included in facility survey
Kyamulibwa Rakai
Total no. of clinics (n(%)) 10 (100.0) 14 (100.0)
Type of facility (n(%))
Large clinic/small health center 6 (60.0) 12 (85.7)
Large health center/hospital 4 (40.0) 2 (14.3)
Management authority (n(%))
Government 4 (40.0) 12 (85.7)
Faith-based organisation 3 (30.0) 0 (0.0)
Other NGO 3 (30.0) 2 (14.3)
HIV-related services (n(%))
HIV counselling and testing 10 (100.0) 14 (100.0)
PMTCT 8 (80.0) 14 (100.0)
HIV care (incl. pre-ART) and treatment 10 (100.0) 14 (100.0)
HR and patient load (median (range))
No. of cliniciansa 3.0 (2.0–6.5) 2.0 (0.0–7.0)
No. of nurses/midwives 4.0 (0.0–9.0) 3.3 (1.0–8.0)
No. of counsellors 1.5 (0.0–67.0)d 1.0 (0.0–10.0)
No. of HIV testing clients/week 19.0 (1–2011.0)d 58 (4–262)
No. of ART clients/week 3.0 (0–270.0) 49 (19–508.0)
No. of weekly HIV testing clients/staffb 1.8 (0.0–4.3) 6.9 (0.5–29.3)
No. of weekly ART clients/clinician or nurse 0.3 (0.0–29.8) 10.7 (4.8–253.9)
Staff turnoverc 7.8 (0–20.0) 4.8 (2.0–10.0)
Source [13]
aDoctor, clinical officer, and assistant medical officer
bNurse, midwife, nursing aide, counsellor or community outreach worker
cTotal staff (nurses, clinicians, aides, counsellors, outreach)/number left in past year
dOne facility included all outreach workers, which represents the high end of the range
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Rakai implemented fewer policies to support PLHIV. Both
sites reported only partial implementation of two explicit
polices on patient coordination/tracking: testing repeated
3 months after first test in pregnancy and/or in the third
trimester (50% in Kyamulibwa, 35.7% in Rakai), and HIV
test result recorded in patient-retained card (50% both
sites). Regarding indicators for which there was no explicit
policy in this setting: no facilities in Kyamulibwa and one
in Rakai provided dedicated testing for most-at-risk popu-
lations (MARPs) such as commercial sex workers, injec-
tion drug users and men who have sex with men. While
policy states that testing should be provided to MARPs,
the guidance does not explicitly name these groups, as
some are not legally recognised.
Implementation of policies promoting access to HIV
treatment and PMTCT
Table 4 summarises implementation of policies influen-
cing access to HIV treatment (measured in either PMTCT
or ART clinics). Out of 17 explicit policies, 15 were widely
implemented in Rakai versus 13 in Kyamulibwa; nine of
these were the same indicators. Kyamulibwa reported par-
tial implementation for the five remaining explicit policies:
free ART services (60% of facilities), ART initiation and
provision 5 days a week (30%), ART initiation performed
by nurses and midwives (70%) and renal function tests
prior to ART initiation (40%). For two explicit policies,
there was minimal implementation coverage across facil-
ities in Rakai: renal function tests prior to ART initiation
(0%) and two adherence counselling sessions prior to ART
(50%). No facilities across Kyamulibwa or Rakai reported
offering treatment services to MARP; however, as with
HCT for these groups, policy did not name types of
MARPs explicitly. One facility in Kyamulibwa reported
initiating treatment at 500 CD4 cells/mm3, despite this
not being policy at the time of the survey.
Implementation of policies influencing retention on ART
Table 5 summarises implementation of policies influencing
retention on ART. Of 12 explicit policies, nine were widely
implemented in Kyamulibwa compared to eight in Rakai.
The sites differed in implementation of explicit policy on
TB integration within facilities (100% of facilities in Kya-
mulibwa versus 69.2% in Rakai). Implementation of pol-
icies on support to PLHIV was weaker. A higher
proportion of facilities in Rakai implemented support
Table 3 Implementation of policies influencing access to HIV counselling and testing
≥75%)
≥75%) ≤25 - 0%)
≤25 - 0%)
ANC antenatal clinic, CSW commercial sex worker, MSM men who have sex with men
§In clinics with ANC only
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groups (available either onsite or through referral within
the district) and home-based care (93% for both), com-
pared to Kyamulibwa (50% and 70%, respectively). There
was partial implementation of explicit policy on provision
of nutritional supplements to malnourished PLHIV in
both Kyamulibwa and Rakai. Only 14.3% facilities in Rakai
reported conducting individual counselling over group
counselling for adherence, despite policy documents
noting the value added in ensuring one-to-one counsel-
ling. No facilities in both HDSS offered or had in stock
prophylactic isoniazid preventive therapy (IPT). Two
facilities in Kyamulibwa reported implementation of home
visits following poor adherence despite this not being na-
tional policy.
Quality of care indicators
Overall, Kyamulibwa performed less well on the quality
of care indicators investigated compared to Rakai. The
difference in stock-outs of testing kits between sites was
particularly stark: only one facility in Rakai reported
stock-out, which was also classified as frequent (i.e. last-
ing >=2 weeks), whereas 70% of facilities in Kyamulibwa
Table 4 Implementation of policies influencing access to HIV treatment (measured in PMTCT and ART units)
Source: [23–25]
ANC antenatal clinic, CSW commercial sex worker, MSM men who have sex with men, AMO accredited medical officer
*>10% sites missing data
‡Total number of facilities providing PMTCT in Kyamulibwa is 8
§ARV prophylaxis or treatment for mother and prophylaxis for baby
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reported stock-outs in the past year and 50% reported
these as frequent. The same number of facilities in both
sites reported stock-outs of ARVs (20% in Kyamulibwa,
14% in Rakai) and treatments for OIs (30% in Kyamulibwa,
21% in Rakai) in the past year. Only half of the facilities in
both sites reported having seen national testing guidelines,
but more facilities in both sites reported having seen
national treatment guidelines (Table 6).
Influences on policy implementation: findings from key
informants
Seven informants (four male, three female) with know-
ledge of the two HDSS were interviewed. Informants shed
light on the patterns of reported implementation, possible
reasons for differences between sites and the diverse polit-
ical, social, structural factors influencing the translation of
policy into practice in the Ugandan setting. Key infor-
mants were largely successful at predicting, when un-
prompted, which policies were well implemented and
where implementation gaps existed in the two HDSS and
along the treatment cascade. Reporting of reasons for dif-
ferences was highly consistent between respondents, but
senior members of the HDSS and the District Health Offi-
cer were most aware of implementation gaps. Findings
have been detailed below under the domains detailed in
Fig. 1 (characteristics of individuals and institutions, char-
acteristics of intervention, processes and context).
Characteristics of individuals and institutions
When queried on the main reason for implementation
gaps observed, all respondents noted the necessity of
donor financial support to ensure implementation, in par-
ticular for treatment services from the United States
President’s Emergency Plan for AIDS Relief (PEPFAR) and
the Global Fund to Fight AIDS, TB, and Malaria. In Rakai,
the adequate provision of ART, in particular, was seen as
contingent upon PEPFAR’s funding for medication:
For example, when [the WHO] said they upgrade to
the CD4 500 we had a commitment from PEPFAR
Table 5 Implementation of policies influencing retention on ART
Source: [23, 24, 26]
*<10% sites missing data
§Not more than twice
¶Onsite or through referral within district
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that they will be able to supply us with drugs for the
additional number of people who are now eligible.
Unless that is done we can’t support it. [R5]
The widespread implementation of many policies
relating to treatment in Rakai was attributed to the
volume of funding from PEPFAR, the Bill and
Melinda Gates Foundation and support from the
Department of Health, funds which were not received
to the same extent in Kyamulibwa. Additionally, re-
spondents noted that as facilities in the Rakai HDSS
are pre-dominantly government-run and largely have
the same funding source, there was coherence in
communication among the facilities.
When respondents were asked to name a policy
that they were confident would be implemented in fa-
cilities, all stated Option B+, the initiation of lifelong
treatment to pregnant and breastfeeding women.
Several respondents commented how many individ-
uals and institutions from the global level to health
workers on the ground had worked together to en-
sure facility implementation:
…the leadership of Ministry also really was very
supportive of PMTCT as a whole… Then WHO
supported us through the guidelines, and UNICEF
[United Nations International Children’s Emergency
Fund]. Everyone, all the organizations were very
instrumental. [R3]
Some respondents noted, however, that national prior-
ities were not always aligned with donor priorities stat-
ing that it was “partner interest that takes precedent”
[R3] and that policy evolution was often “donor driven”
[R3]. Most noted that WHO and others pushed policy
changes, despite Uganda and, in particular, the Rakai
HDSS, being a leading setting for HIV research and
policy innovation. Donor prioritisation and investment
toward high-impact interventions were seen to result in
insufficient attention being paid to public health infra-
structure, to the point of a “hollowing out” [R4], as one
respondent put it. Donors were considered to focus
more on provision of medicines, rather than on trad-
itional prevention activities. Further, recent donor fund-
ing declines were attributed to the cessation in provision
of services to support PLHIV in HDSS in Kyamulibwa:
Those sorts of soft cuddly things really have been
removed… For example, MRC [Medical Research
Council] used to have a lot of community helpers
groups, but in 2011 after that 5-year funding phase
they just said no and that the money from DFID is
just not there anymore, so it disappears. [R2]
Characteristics of the intervention
Many respondents underlined the importance of strong
scientific evidence to facilitate policy implementation:
“in case there is some ground-breaking evidence, like say
PMTCT option B+, implementation will be done earlier”
[R1]. Option B+ roll-out was also facilitated by the
ability to rapidly view results, with demonstrated im-
pact on newborn HIV incidence in a short time frame
providing additional motivation for donor support of
this policy:
Option B+ has given us tangible results. Results that
are visible by each and everyone[…], it’s one of those
that have been implemented so well and we are
Table 6 Facility implementation of quality of care indicators
Kyamulibwa Rakai
Total no. of clinics (n(%)) 10 (100) 14 (100)
National testing guidelines availablea 5 (50) 7 (50)
National treatment guidelines availablea 7 (70) 12 (86)
≤1 staff received HIV testing training in past 2 years 4 (40) 13a (100)
QOC audits at least once/year 10 (100) 11a (85)
At least one test kit stock-out in past year 7 (70) 1 (7)
Frequent test kit stock-outsb 5 (50) 1 (7)
CTX prophylaxis in stock in pre-ART 10 (100) 14 (100)
At least one stock-out 1st line ARVs in past year 2 (20) 2 (14)
Frequent stock-out of 1st line ARVsb 2 (20) 2 (14)
At least one stock-out of OI drugs in past yearc 3 (30) 3 (21)
Frequent stock of OI prophylaxisb 3 (30) 2 (14)
QOC quality of care, CTX co-trimoxazole, OI opportunistic infection
aSeen or not seen, any guideline
bMore than once in past year or one stock-out lasting for over 2 weeks
cCo-trimoxazole, fluconazole or isoniazid preventive therapy (IPT)
McRobie et al. Implementation Science  (2017) 12:47 Page 8 of 12
increasingly getting HIV-negative babies born to
HIV-positive mothers. [R6]
The low complexity of the task also enabled Option B+
roll-out. Since it was a simplification of the previous regi-
men (option A), it required minimal staff training or ad-
justment to practice and could now be performed by
lower cadres of staff (nurses, clinical officers). Conversely,
policies that were more complex, such as those that in-
clude a greater number of steps, require particular skill in
delivery, or involve collaboration among a number of ac-
tors, were less well implemented. Support services for
PLHIV on ART, for example, exhibited minimal imple-
mentation coverage for this reason:
The support groups, it’s good in theory. [The AIDS
Support Organization] has had some success… but it’s
hard. A support group needs to be a group of local
people who can help each other out… It’s not something
that’s easy for a clinic to put in place. [R2]
Process
All respondents identified the importance of planning for
policy implementation, seen to be particularly effective in
the more recent successful Option B+ roll-out. When there
were small (and non-complex) amendments to policy, in-
formation was shared from the Ministry to the District
Health Office and then onto facilities, usually in the form of
a written memo. When there were larger changes to policy,
facilities were supported through training and on-the-job
mentorship. All communication was described positively.
Incremental and prioritised scale-up of policies was
highlighted as facilitating implementation (e.g. by targeting
central regions logistically easier to access). Phased ap-
proaches enabled piloting and learning from experience to
allow revision of practices for scale-up:
Option B+, it was very successful because it was
planned, it was a phased approach. We did not roll
out to the whole country at once. We first went for
the central region then we kept on rolling-out to other
regions. [R5]
The process of monitoring progress, reflecting on re-
sults and adapting was also cited as critical, as well as
demand-generation activities to engage PLHIV. It was
acknowledged, however, that phased scale-up was neces-
sary due to budget and resource constraints and one
respondent described the prioritisation process as
“political” and “very bureaucratic” [R5], thus causing un-
necessary delays in implementation.
Innovations to simplify the treatment pathway for
PLHIV were cited as an explanation for why some sites
in Rakai did not widely implement policies that may act
as a barrier to treatment initiation, e.g. only 50% of sites
implemented the policy that recommends two adherence
counselling sessions prior to ART initiation.
Context
Respondents considered constraints on complete policy
implementation to be attributable to a range of context-
ual factors, with one respondent commenting: “infra-
structure and human resources are insufficient to
implement the policies” [R1]. Some respondents, how-
ever, noted that Ugandan facilities fare well in terms
of HIV service delivery compared with other countries
in the region and that these HDSS facilities may also
perform much better than others in Uganda: “if you
went to the North of the Uganda, it’s absolutely lux-
ury down in Rakai”. [R2]
However, all underscored the importance of structural
factors in inhibiting policy implementation. Human re-
source constraints presented a critical operational chal-
lenge for HIV services, with too few staff available to
provide necessary services, primarily because of MoH
funding constraints. High patient load was seen to im-
pact on quality of care, likely in turn to inhibit patient
engagement with care:
Imagine, if you will, on a Monday morning where we
have a clinic officer and he has about 100 to 120
clients that are coming in. This is extremely
overwhelming and therefore impacting on the
quality of services. [R7]
Staff remuneration and career development prospects
were also noted as problematic. Staff mobility was also
emphasised, in particular, due to the loss of institutional
knowledge. These issues are further perpetuated by
training deficiencies, low salaries and heavy workloads.
Human resource constraints were also cited for their im-
pact on commodity management:
Sites don’t have dedicated logistics managers. The
staff, she’s the doctor, she’s the nurse, she’s the
soul, she’s everything. You need dedicated logistics
managers. [R1]
The importance of adequate health management infor-
mation systems was also commonly highlighted, with
the need for adequate records to report patient history
and trace patients between clinics. It was noted that
there was no national or even regional tracking system.
One respondent commented that improving these sys-
tems might impact on patient retention. This is of im-
portance as more patients may be initiated on treatment
earlier; retention rates will need to be improved:
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Strategies for improving retention, of course one is
infrastructure. If you improve infrastructure you
improve clients flow, minimize waiting time, avoid
stock-outs of essential drugs. I think all those we need
to do … then tracking those clients who didn’t get lost
to follow-up. [R1]
The political context was also influential, notably on
policy and implementation gaps for testing and treat-
ment services for MARPs, and it was noted that facil-
ities may have been fearful to openly report provision
of these services: “Because they won’t report they are
doing that as it is illegal. There will be a lot of places
that will be providing services for those people but
not in name”. [R2]
Discussion
This study has reviewed the implementation of HIV pol-
icy in Uganda within two rural HDSS in 2013. To our
knowledge, this is the first comprehensive assessment
conducted in the region that specifically contrasts the
policy and practice of a range of indicators determinant
in ensuring progression of PLHIV from diagnosis
through to retention on long-term treatment.
The findings show that the majority of policies that
may influence access to HCT, access to treatment for
those diagnosed positive or retention in care were
widely implemented across facilities in both sites. This
is a notable achievement given the inherent health
system weaknesses that can obstruct effective service
delivery, which has been previously observed in many
settings in Uganda [5].
There were, however, shortcomings either in both sites
or in several areas. There were more commonalities than
differences in implementation between the sites, with a
similar pattern of practice observed for each policy (i.e.
if Kyamulibwa reported wide implementation of a policy,
so did Rakai), which suggests that factors influencing
implementation may be common to both sites. However,
Rakai achieved higher levels of implementation for
policies relating to provision of treatment. Both
Kyamulibwa and Rakai reported mixed implementa-
tion of policy indicators influencing retention in care
(notably indicators providing support for PLHIV).
The qualitative findings identified a range of influences
on policy implementation, usually facilitating practice ra-
ther than inhibiting. The commonalities between the im-
plementation analysis and reports from informants give
confidence to the accuracy of the self-report in the
facility survey. Respondents highlighted several positive
aspects of the policy cycle in Uganda, including substan-
tial donor investment and support, phased implementa-
tion and routine hierarchical processes for information
dissemination. However, informants strongly emphasised
the inadequate quality of care and gaps in service
provision considered to be common in the Ugandan
context [5].
The pattern of implementation appears to follow the
strength of recommendation and evidence-based for for-
mulating it. Policies providing impactful results in the
short term also appeared to be a strong enabling factor
in implementation, as noted with the successful roll-out
of Option B+. This may indicate evidence-driven policy
implementation or reflect the donor-driven political en-
vironment in which it is preferable to deliver tangible re-
sults and maximum impact with the financial support
they provide [5, 14]. As noted by our informants, such
approaches may not always align with national priorities
or local needs, with prevention activities often under-
resourced. Emphasis by donors in support of medical
management of HIV through ART may result in over-
sight of implementation of interventions supporting pa-
tient coordination or retention in care, which strengthen
the comprehensive care package necessary for PLHIV to
be maintained in the long-term care system. Retention
strategies tend to have variable efficacy or may be com-
plex to implement (as with patient support groups,
noted by key informants) [15]. This leads to a “vicious
cycle” in which donors have little incentive to support
such strategies, and less investment will result in less im-
pact and less future evidence. The comparison is par-
ticularly stark when reviewed alongside implementation
of clinical policies such as Option B+, as the successes
will be harder to estimate or will appear over longer
time horizons.
These oversights are particularly crucial given the re-
cent changes to WHO guidance to recommend immedi-
ate ART initiation following HIV. The change in policy
from Option A to Option B+ shares some similarities
with this recent change in treatment eligibility by the
WHO, and efforts should be made to learn from
Uganda’s response to the former. This study indicates
Option B+ was widely implemented across facilities
within a short time frame due to support (political and
economic) from individuals and institutions involved.
Further, given that the policy was a simplification of a
previous protocol, the training requirements were min-
imal, which enabled lower cadres of staff to perform the
task. This bodes well for implementation of immediate
ART as this is also a simplification of previous treatment
protocol. However, the capacity of HIV programmes to
retain high patient numbers in care may be of concern.
In this study, facilities were already suffering stock-outs
and human resource challenges; these systemic weak-
nesses are likely to be amplified with higher patient
loads and development of resistance to ART may be-
come increasingly problematic [16, 17]. While these
changes in policy have the potential to markedly
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improve individual and population health, significant
additional financial resources will need to be mobilised
in the short term for commodities, laboratory facilities
and facility-level and personnel costs [18, 19]. Pre-
existing gaps in policy and practice along the diagnosis-
to-treatment cascade could limit the effectiveness of this
strategy [4].
Funding from international donors continues to be the
main route through which HIV services are financed in
Uganda; in 2011, it was estimated that 95% of the
programme was funded by external donors, with PEPFAR
responsible for 73% [5]. Therefore, support for implemen-
tation of policies to improve the comprehensive care pack-
age provided to PLHIV will require donor backing. Key
informants in this study reported on the complex dynamic
of misalignment of goals between the government and do-
nors in assessing priorities, making reference mostly to a
lack of support for prevention activities, but also noting
that support for health system strengthening would not be
available [20]. The Uganda AIDS Commission 2013 Coun-
try Progress Report indicate there is a need for support or
leadership for strategies that enable strengthening of co-
ordination of care and care provision for the later stages
of the treatment continuum in which PLHIV should ul-
timately spend more time [5]. The WHO’s 2015 ARV
Guidelines include a number of operational recommenda-
tions on how to simplify and streamline care in order to
reduce clinic burdens, and the adoption of such strategies
should be considered if the programme is to sustain
PLHIV in care over longer time horizons [21].
Study limitations
The facilities may not be representative of facility perform-
ance across Uganda, as routine research activities within
the HDSS may have benefited service delivery. Health fa-
cility survey data may be affected by reporting bias, result-
ing in an overestimation of implementation, as managers
may have been inclined to report practice in the best light.
However, the number of gaps in implementation reported
and the alignment with findings from key informants gives
us confidence that reporting was relatively truthful. The
policy and practice comparison presents a picture of a
well-functioning health system; however, the qualitative
interviews provide an alternative view. Human resources,
infrastructure and health management information system
limitations may be limiting the quality of care that is
provided to patients, which might influence patient en-
gagement with the health system [15]. This generates hy-
potheses for further investigation to develop a deeper
understanding of policy implementation. ALPHA’s on-
going qualitative research on the HIV continuum of care
among people living with HIV in the HDSS may further
inform findings on health facility performance and pro-
vider behaviour in this setting and help validate our
findings. “Mystery client” patient observations, in particu-
lar, would prove insightful. This analysis was also not able
to estimate the health impact of each policy, so it is diffi-
cult to draw conclusions about the effect that implemen-
tation gaps have on epidemiological outcomes.
Conclusions
This study provides insight into implementation status of
MoH policies for HIV care in two HDSS sites in Uganda
in 2013. While overall implementation was strong across
the majority of policies, implementation coverage was fre-
quently lower than 100% for many policies implying there
is still a gap in complete implementation of most national
HIV policies in Uganda, even in the relatively well-
resourced HDSS. Key informants indicated that quality of
care provided may have been limited in this setting, how-
ever, and noted the emphasis from donors to fund treat-
ment, with minimal support for policies relating to
coordination and retention of patients. Attention should
be given to closing gaps in implementation (both at stages
of the cascade and in the variability of facilities to adopt
national policies) to improve the comprehensive care
package that should be provided along the diagnosis-to-
treatment cascade. This is particularly important as the
country endeavours to respond to changing global guid-
ance from the WHO, notably the change to immediate
ART eligibility. While focus on entry into the care cascade
remains vitally important, failure to ensure maintenance
in care downstream in the care pathway could result in
greater patient attrition from already overburdened facil-
ities. Novel service delivery strategies to improve efficiency
should be considered.
Abbreviations
ALPHA: Network for Analysing Longitudinal Population-based data on
HIV in Africa; ART: Antiretroviral treatment; CSW: Commercial sex workers;
CTX: Co-trimoxazole; HCT: HIV counselling and testing; HDSS: Health and
demographic surveillance site; HIV: Human immunodeficiency virus;
HMIS: Health management information systems; HR: Human resources;
IDU: Injection drug user; IPT: Isoniazid Preventive Therapy; KI: Key informant;
MARP: Most-at-risk persons; MoH: Ministry of Health; MSM: Men who have
sex with men; NGO: Non-governmental organisation; OI: Opportunistic
infection; PEPFAR: Presidents Emergency Fund for AIDS Relief;
PMTCT: Prevention of mother to child transmission; TB: Tuberculosis;
UNAIDS: Joint United Nations Department for HIV/AIDS; WHO: World
Health Organization
Acknowledgements
We are grateful to all of our key informant participants and in-charge staff in
the facilities for the time they dedicated to participate in this study. We also
thank the reviewers of this manuscript for their valued comments and feedback.
Funding
The policy analysis and implementation research were funded through the
ALPHA network by a grant from the Bill and Melinda Gates Foundation:
“Deaths among HIV infected adults in African populations since the introduction
of Antiretroviral Treatment” OPP1082114. AW is funded by a Population Health
Scientist award, jointly funded by the UK Medical Research Council (MRC) and the
UK Department for International Development (DFID) under the MRC/DFID
Concordat agreement and is also part of the EDCTP2 programme supported by
the European Union.
McRobie et al. Implementation Science  (2017) 12:47 Page 11 of 12
Availability for data and materials
The datasets created and/or analysed during the current study are not publicly
available. Please contact the author with data queries.
Authors’ contributions
AW, KC, BZ and JT are responsible for the initial conception of the ALPHA
policy review and facility survey research in HDSS sites across the whole
ALPHA network. EM and KC designed the protocol for the Uganda secondary
analysis and key informant research. KC, JN FK, TL and BZ designed the policy
review tool. KC, AW, JT, JN, TL and GN designed the health facility survey
questionnaire. GN and FK conducted the policy review, with the inputs from TL
and KC. JT, JN and GN oversaw the administration of the facility survey. EM
designed the key informant topic guide with the inputs from KC. EM, KC and JE
conducted the health facility survey data analysis; EM, KC and FK conducted the
policy analysis. EM analysed the in-depth interview data. EM drafted and
finalised the manuscript, with review and inputs from all co-authors. All authors
read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Consent to publish facility survey results was obtained from in-charge staff in
facilities. Consent to publish quotations from interview transcripts was
obtained from all key informants.
Ethics approval and consent to participate
Ethical approval to collect health facility data and to conduct KI interviews
was received from the Science and Ethics Committee of the Uganda Virus
Research Institute, the IRB of record for both Medical Research Council and
Rakai Health Sciences Program (reference number: GC/127/15/06/436) and
registered with the Uganda National Council for Science and Technology.
This research study was also approved by the ethics committee of The
London School of Hygiene and Tropical Medicine (reference number: 9001).
Uganda national policies for HIV were freely available online. All participants
provided their written informed consent prior to the participation in the study.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Imperial College London, Norfolk Place, London W2 1PG, UK. 2London
School of Hygiene and Tropical Medicine, Keppel Street, London, UK. 3MRC/
UVRI Uganda Research Institute on AIDS, Entebbe, Uganda. 4Makerere
University Walter Reed Project, Kampala, Uganda. 5Rakai Health Sciences
Program, Entebbe, Uganda.
Received: 12 April 2016 Accepted: 16 March 2017
References
1. Larson H, Bertozzi S, Piot P. Redesigning the AIDS response for long-term
impact. Bull World Health Organ. 2011;89:846–52.
2. UNAIDS. How AIDS changed everything. Geneva: UNAIDS; 2015.
3. Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, Nachega JB, Dybul
M, Hogg RS. Life expectancy of persons receiving combination antiretroviral
therapy in low-income countries: a cohort analysis from Uganda. Ann Intern
Med. 2011;155:209–17.
4. Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD. Quantifying and
addressing losses along the continuum of care for people living with HIV
infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2012;15:
17383.
5. Uganda Ministry of Health. HIV and AIDS Uganda country progress report.
Kampala: Uganda Ministry of Health; 2013.
6. Reniers G, Slaymaker E, Nakiyingi-Miiro J, Nyamukapa C, Crampin AC, Herbst
K, Urassa M, Otieno F, Gregson S, Sewe M, Michael D, Lutalo T, Hosegood V,
Kasamba I, Price A, Nabukalu D, Mclean E, Zaba B. Mortality trends in the
era of antiretroviral therapy: evidence from the Network for Analysing
Longitudinal Population based HIV/AIDS data on Africa (ALPHA). AIDS. 2014;
28:S533–42.
7. Church K, Kiweewa F, Todd J, Oti S, Njage M, Mpandaguta E, Mugurungi O,
Geubbels E, Mwangome M, Mamdani M, Dasgupta A, Nakiyingi-Miiro J,
Gomez-Olive FX, Wringe A, Zaba B, Crampin A. A comparative analysis of
national HIV policies in six African countries with generalised epidemics:
influences on access to testing, access to treatment and retention in care.
Bull World Health Organ. 2015;93:457–67.
8. Putzel J. The politics of action on AIDS: a case study of Uganda. Public Adm
Dev. 2004;24:19–30.
9. Dickinson C, Buse K. Understanding the politics of national HIV policies: the
roles of institutions, interests and ideas. 2008.
10. Walt G, Gilson L. Reforming the health sector in developing countries.
Health Policy Plan. 1994;9:353–70.
11. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC.
Fostering implementation of health services research findings into practice:
a consolidated framework for advancing implementation science.
Implement Sci. 2009;4:50.
12. Slaymaker E, Bwanika JB, Kasamba I, Lutalo T, Maher D, Todd J. Trends in
age at first sex in Uganda: evidence from Demographic and Health Survey
data and longitudinal cohorts in Masaka and Rakai. Sex Transm Infect. 2009;
85(Suppl 1):i12–9.
13. Church K, Machiyama K, Todd J, Njamwea B, Mwangome M, Hosegood V,
Michel J, Oti S, Nyamukapa C, Crampin AC, Nyaguara A, Nakigozi G, Michael
D, Gomez-Olive FX, Nakiyingi-Miiro J, Zaba B, Wringe A. Identifying gaps in
HIV service delivery across the diagnosis-to-treatment cascade: findings
from health facility surveys in six sub-Saharan countries. J Int AIDS Soc.
2017;20:21188.
14. Orem JN, Mafigiri DK, Nabudere H, Criel B. Improving knowledge translation
in Uganda: more needs to be done. Pan Afr Med J. 2014;17(Suppl 1):14.
15. World Health Organization. Retention in HIV programmes. Geneva: World
Health Organization; 2012.
16. Gupta RK, Jordan MR, Sultan BJ, Hill A, Davis DHJ, Gregson J, Sawyer AW,
Hamers RL, Ndembi N, Pillay D, Bertagnolio S. Global trends in antiretroviral
resistance in treatment-naive individuals with HIV after rollout of
antiretroviral treatment in resource-limited settings: a global collaborative
study and meta-regression analysis. Lancet. 2010;380:1250–8.
17. Barth RE, van der Loeff MFS, Schuurman R, Hoepelman AIM, Wensing AMJ.
Virological follow-up of adult patients in antiretroviral treatment
programmes in sub-Saharan Africa: a systematic review. Lancet Infect Dis.
2010;10:155–66.
18. Dutta A, Barker C, Kallarakal A. The HIV treatment gap: estimates of the
financial resources needed versus available for scale-up of antiretroviral
therapy in 97 countries from 2015 to 2020. PLoS Med. 2015;12.
19. Stover J, Gopalappa C, Mahy M, Doherty MC, Easterbrook PJ, Weiler G, Ghys
PD. The impact and cost of the 2013 WHO recommendations on eligibility
for antiretroviral therapy. AIDS. 2014;28(Suppl 2):S225–30.
20. Bernstein M, Oomman N, Rosenzweig S. Following the funding for HIV/
AIDS: a comparative analysis of the funding practices of PEPFAR, the Global
Fund and World Bank MAP in Mozambique, Uganda and Zambia. Cent
Glob Dev. 2007;2007:1–75.
21. World Health Organization. Guideline on when to start antiretroviral therapy
and pre-exposure prophylaxis for HIV. Geneva: World Health Organization;
2015.
22. Slaymaker E, Todd J, Marston M, Calvert C, Michael D, Nakiyingi-Miiro J,
Crampin A, Lutalo T, Herbst K, Zaba B. How have ART treatment
programmes changed the patterns of excess mortality in people living with
HIV? Estimates from four countries in East and Southern Africa. Glob Health
Action. 2014;7:1–10.
23. Uganda Ministry of Health. Uganda antiretroviral treatment guidelines.
Kampala: Uganda Ministry of Health; 2011.
24. Uganda Ministry of Health. The integrated national guidelines on
antiretroviral therapy prevention of mother to child transmission of HIV
infant & young child feeding. Kampala: Uganda Ministry of Health; 2012.
25. Uganda Ministry of Health. Addendum to the national antiretroviral
treatment guidelines. Kampala: Uganda Ministry of Health; 2013.
26. Uganda Ministry of Health. Uganda national antiretroviral therapy
adherence strategy. Kampala: Uganda Ministry of Health; 2011.
McRobie et al. Implementation Science  (2017) 12:47 Page 12 of 12
